Analysis of clinical characteristics of mesalazine-induced cardiotoxicity

Background: Mesalazine is the first-line inflammatory bowel disease (IBD) treatment. However, it can cause fatal cardiotoxicity. We aimed to analyze the clinical characteristics of mesalazine-induced cardiotoxicity and provide evidence for clinical diagnosis, treatment, and prevention. Methods: We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junyu, Duan, Tengfei, Fang, Weijin, Liu, Shikun, Wang, Chunjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520406/
https://www.ncbi.nlm.nih.gov/pubmed/36188558
http://dx.doi.org/10.3389/fphar.2022.970597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520406/
https://www.ncbi.nlm.nih.gov/pubmed/36188558
http://dx.doi.org/10.3389/fphar.2022.970597

Ejemplares similares